Galectin‐3, a marker of well‐differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia
- 21 January 2002
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 40 (1) , 80-87
- https://doi.org/10.1046/j.1365-2559.2002.01304.x
Abstract
Galectin‐3, a marker of well‐differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia Aims: The distribution of galectin‐3, a widely recognized marker of well‐diff...Keywords
This publication has 28 references indexed in Scilit:
- PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid CarcinomaScience, 2000
- Expression of galectin‐3 in fine‐needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasmsCancer, 1999
- Expression of the endogenous galactose‐binding protein galectin‐3 correlates with the malignant potential of tumors in the central nervous systemCancer, 1997
- Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratinsVirchows Archiv, 1997
- Galectins: A family of animal β-galactoside-binding lectinsPublished by Elsevier ,1994
- Expression of a 31‐kDa lactoside‐binding lectin in normal human gastric Mucosa and in primary and metastatic gastric carcinomasInternational Journal of Cancer, 1994
- Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissuesCancer, 1991
- Evidence for the role of 34‐kDa galactoside‐binding lectin in transformation and metastasisInternational Journal of Cancer, 1990
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- A reliable sign of papillary carcinoma of the thyroid?The American Journal of Surgical Pathology, 1979